Loading data for BMRA — first visit, this takes a few seconds.
Biomerica, Inc. (BMRA)
NasdaqCM: BMRA
· Real-Time Price · USD
2.31
+0.09 (4.05%)
At close: Sep 04, 2026, 3:58 PM
The price, the headline numbers and the latest news, in one place.
Biomerica, Inc. (BMRA) Stock Price, Analysis & Data
4.05% (1D)
| Bid | 1.6 |
| Market Cap | 10.6M |
| Revenue (ttm) | 4.45M |
| Net Income (ttm) | -3.77M |
| 0.00 | |
| -1.3 | |
| n/a | |
| 5.92 | |
| P/B (ttm) | 2.81 |
| P/S (ttm) | 2.38 |
| Earnings Date | n/a |
| Ask | 2.98 |
| Volume | 54,603 |
| Avg. Volume (20D) | 67,446 |
| Open | 2.27 |
| Previous Close | 2.22 |
| Day's Range | 2.21 - 2.35 |
| 52-Week Range | 1.45 - 3.21 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About BMRA
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients to aid in the diagnosis of diseases, food intolera...
Industry Medical Devices
Sector Healthcare
IPO Date Sep 7, 1984
Employees n/a
Stock Exchange NasdaqCM
Ticker Symbol BMRA
Website https://www.biomerica.com
Financial Performance
In 2026, Biomerica's revenue was 4.45M, a decrease of -16.16% compared to the previous year's 5.31M. Earnings were -3.78M, a decrease of -24.09%.
Financial StatementsEarnings Surprise
Biomerica has released their quarterly earnings on Apr 14, 2023:
- Revenue of $875K misses estimates by $0, with 16.82% YoY growth.
- EPS of -0.96 misses estimates by -1.12, with 20.00% YoY growth.
